A feasibility combination study of S-1 and carboplatin in patients with interstitial pneumonia (IP) and advanced non small cell lung cancer (NSCLC)
Latest Information Update: 12 Dec 2015
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer; Pneumonia
- Focus Therapeutic Use
Most Recent Events
- 12 Dec 2015 New trial record